Several HMOs Stung in N.Y. Test Of Consumer Law


More than half of 31 HMOs in New York state failed to properly respond to telephone requests for information they are legally required to provide, according to Attorney General Dennis Vacco.

The state's Managed Care Consumer Bill of Rights, enacted last year, includes a requirement that plans provide subscriber contracts and member handbooks upon request. To test compliance with the law, the attorney general's office set up a survey of 31 HMOs. Each plan received 16 telephone requests for information. Eighteen of the plans failed to provide the information more than half the time, while five plans provided the information at least 14 times.

Vacco served notice on the 18 that failed the test that they could be sued. Each of the 18 plans, which include Cigna Healthcare of New York, Empire Blue Cross and Blue Shield and Prudential Health Plan of New York, scheduled a conference with the attorney general's office. The HMOs will be asked to sign an agreement on how each plans to comply with the law. The attorney general's office also seeks to put a financial penalty in the agreement.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.